Musk’s Starlink rival Eutelsat shares plummet 7% after report of SoftBank cutting its stake

Musk’s Starlink rival Eutelsat shares plummet 7% after report of SoftBank cutting its stake


French satellite group Eutelsat, often seen as Europe’s answer to Elon Musk’s Starlink, saw its share price plummet Wednesday following a report that Japanse investor SoftBank cut its stake in the company.

Shares in Eutelsat were last trading 7.2% lower as of 4.41 a.m. ET.

The moves come following a Reuters report that SoftBank has sold 36 million rights, corresponding to around 26 million shares and around half their stake in the satellite operator.

Eutelsat is the owner of the satellite internet provider OneWeb, which it merged with in 2023 in a bid to challenge Starlink’s dominance in the market.

But the French group has struggled to tap into the U.S. company’s market share. Eutelsat currently has more than 600 satellites in orbit compared to Starlink’s over 6,750, according to the companies’ websites.

After soaring more than 600% in early March this year, as Europe scrambled to bolster its tech sovereignty in the wake of the U.S. cutting military support to Ukraine, Eutelsat shares have since dropped more than 70%.

The company is seen as crucial to Europe’s tech sovereignty ambitions. In June the French state led a 1.35 billion euro ($1.57 billion) investment in Eutelsat, becoming its biggest shareholder with a roughly 30% stake.

Eutelsat and SoftBank have been approached for comment.



Source

Judge dismisses Trump defamation lawsuit against Murdoch, WSJ about Epstein letter
World

Judge dismisses Trump defamation lawsuit against Murdoch, WSJ about Epstein letter

U.S. President Donald Trump and Rupert Murdoch. Julia Demaree Nikhinson | Jonathan Ernst | Reuters A federal judge in Florida on Monday dismissed President Donald Trump’s $10 billion lawsuit against media baron Rupert Murdoch and The Wall Street Journal, which claimed the newspaper defamed Trump with a story saying the president had sent a “bawdy” […]

Read More
Dollar strengthens as Iran talks break down — Two reasons why HSBC says the greenback is set to soften
World

Dollar strengthens as Iran talks break down — Two reasons why HSBC says the greenback is set to soften

The U.S. dollar rose on Monday after talks between Washington and Tehran over the weekend failed to yield an agreement to end the war. The greenback rose 0.3% against the Euro to $1.169 and 0.25% against sterling to $1.342 after peace talks broke down and President Trump said the U.S. military would begin a blockade […]

Read More
Revolution Medicines’ potential breakthrough pancreatic cancer drug succeeds in late-stage trial
World

Revolution Medicines’ potential breakthrough pancreatic cancer drug succeeds in late-stage trial

Pancreatic cancer, illustration Nemes Laszl | Science Photo Library | Getty Images Revolution Medicines‘ drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, almost doubling the typical length of survival and slashing the risk of death by 60% versus chemotherapy, the company said Monday. RevMed said its daily pill, daraxonrasib, met all […]

Read More